Peer-reviewed articleOpen access

Correction: Psilocybin's acute and persistent brain effects: a precision imaging drug trials.

Subramanian S, Reneau TR, Perry D, Chacko R, Laumann TO, Flavin K, Horan C, Schweiger J, Metcalf N, Lenze EJ, Snyder AZ iD, Dosenbach NUF, Nicol G iD, Siegel JS

Scientific dataJun 18, 2025License: open accessUnited States, Israel0 citationsDOI: 10.1038/s41597-025-05397-8

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Psilocybin

View paper Full text (PDF)

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticlePsilocybin

Association of Psilocybin Use in Adolescents with Major Depressive Episode

Shah K, Trivedi C, Kamrai D +2

Europe PMC2022

ArticlePsilocybin

Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain.

Spain A, Howarth C, Khrapitchev AA +3

Europe PMC2015

ArticlePsilocybin

Australia to prescribe MDMA and psilocybin for PTSD and depression in world first.

Haridy R

Europe PMC2023